Studies corresponding broadly to the fields of molecular pathogenesis, cellular microbiology, innate and adaptive immunobiology and studies of the systems biology (‘omics) of pathogens are welcome.
Clinical studies (excluding clinical trials but including case reports), and modelling studies (from in situ to in silico) that leverage or are relevant to the aforementioned fields will also be considered.
Editors handling papers will independently make decisions on acceptance, revision, resubmission or rejection based on the referees’ reports.
The Editor-in-Chief or Section Editors will reject papers that are outside the scope of the journal, lack significance or which they believe do not meet the required standards Authors who feel that there are substantial grounds for disagreement with an Editor’s decision should contact the Chief Editor, whose decision will be final.
All manuscripts must be accompanied by a cover letter, which should include a short statement, in 3–4 sentences, describing: The proposals are evaluated and authors may be invited to submit the review if the material is satisfactory and of general interest.
When suggesting reviewers for manuscripts, members of the editorial board and/or suitably qualified scientists should have no close affiliation with the authors and should give an objective review of the manuscript.
aims to publish outstanding primary Research Articles, Short Communications and Mini Reviews reporting on hypothesis- or discovery-driven studies relating to pathogens (eukaryotes, prokaryotes and viruses that infect humans and animals), the host pathogen interaction, the host response to infection and their molecular, cellular, microbial and environmental correlates.
Commentaries and Perspectives on matters related to articles published in or on topics of interest in infectious disease research are also welcome.
The editor will solicit the opinion of expert reviewers.
Upon receiving reviewers’ comments, the editor will decide whether the manuscript is acceptable, or if changes are needed.